Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Vaginal Estrogens on Serum Estradiol Levels in Postmenopausal Women with Breast Cancer Taking an Aromatase Inhibitor
2019-001234-34Phase 4Completed
- Sponsor
- HUS Comprehensive Cancer Center
- Start
- Nov 2019
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of estradiol in breast cancer and atrophic vaginitis, sponsored by HUS Comprehensive Cancer Center. Primary endpoint: Change in serum estradiol levels. Started Nov 2019; status: completed.
02
Drugs
estradiol
03
Conditions
breast canceratrophic vaginitis
Beyond the preview
Go deeper on 2019-001234-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-001234-34.